BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 20129316)

  • 61. Results of a randomized placebo-controlled study of memory training for mildly impaired Alzheimer's disease patients.
    Cahn-Weiner DA; Malloy PF; Rebok GW; Ott BR
    Appl Neuropsychol; 2003; 10(4):215-23. PubMed ID: 14690802
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mindfulness in the Maintenance of Cognitive Capacities in Alzheimer's Disease: A Randomized Clinical Trial.
    Quintana-Hernández DJ; Miró-Barrachina MT; Ibáñez-Fernández IJ; Pino AS; Quintana-Montesdeoca MP; Rodríguez-de Vera B; Morales-Casanova D; Pérez-Vieitez Mdel C; Rodríguez-García J; Bravo-Caraduje N
    J Alzheimers Dis; 2016; 50(1):217-32. PubMed ID: 26639952
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Influence of Educational Attainment on Cognition-Based Intervention Programs for Persons with Mild Alzheimer's Disease.
    Contador I; Fernández-Calvo B; Ramos F; Olazarán J
    J Int Neuropsychol Soc; 2016 May; 22(5):577-82. PubMed ID: 26976668
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer's Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study.
    Remington R; Bechtel C; Larsen D; Samar A; Page R; Morrell C; Shea TB
    J Alzheimers Dis; 2016; 51(4):991-5. PubMed ID: 26967219
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The efficacy of supplementation with the novel medical food, Souvenaid, in patients with Alzheimer's disease: A systematic review and meta-analysis of randomized clinical trials.
    Onakpoya IJ; Heneghan CJ
    Nutr Neurosci; 2017 May; 20(4):219-227. PubMed ID: 26638900
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Using Reiki to decrease memory and behavior problems in mild cognitive impairment and mild Alzheimer's disease.
    Crawford SE; Leaver VW; Mahoney SD
    J Altern Complement Med; 2006 Nov; 12(9):911-3. PubMed ID: 17109583
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease.
    Rijpma A; Meulenbroek O; van Hees AM; Sijben JW; Vellas B; Shah RC; Bennett DA; Scheltens P; Olde Rikkert MG
    Alzheimers Res Ther; 2015; 7(1):51. PubMed ID: 26213579
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effect of souvenaid on functional brain network organisation in patients with mild Alzheimer's disease: a randomised controlled study.
    de Waal H; Stam CJ; Lansbergen MM; Wieggers RL; Kamphuis PJ; Scheltens P; Maestú F; van Straaten EC
    PLoS One; 2014; 9(1):e86558. PubMed ID: 24475144
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of a medical food on body mass index and activities of daily living in patients with Alzheimer's disease: secondary analyses from a randomized, controlled trial.
    Kamphuis PJ; Verhey FR; Olde Rikkert MG; Twisk JW; Swinkels SH; Scheltens P
    J Nutr Health Aging; 2011 Aug; 15(8):672-6. PubMed ID: 21968863
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Multimodal Cognitive Enhancement Therapy for Patients with Mild Cognitive Impairment and Mild Dementia: A Multi- Center, Randomized, Controlled, Double-Blind, Crossover Trial.
    Han JW; Lee H; Hong JW; Kim K; Kim T; Byun HJ; Ko JW; Youn JC; Ryu SH; Lee NJ; Pae CU; Kim KW
    J Alzheimers Dis; 2017; 55(2):787-796. PubMed ID: 27802233
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rationale and clinical data supporting nutritional intervention in Alzheimer's disease.
    Engelborghs S; Gilles C; Ivanoiu A; Vandewoude M
    Acta Clin Belg; 2014; 69(1):17-24. PubMed ID: 24635394
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's disease.
    Shah RC; Kamphuis PJ; Leurgans S; Swinkels SH; Sadowsky CH; Bongers A; Rappaport SA; Quinn JF; Wieggers RL; Scheltens P; Bennett DA
    Alzheimers Res Ther; 2013; 5(6):59. PubMed ID: 24280255
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Souvenaid®: a new approach to management of early Alzheimer's disease.
    Ritchie CW; Bajwa J; Coleman G; Hope K; Jones RW; Lawton M; Marven M; Passmore P
    J Nutr Health Aging; 2014 Mar; 18(3):291-9. PubMed ID: 24626757
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Linguistic development in Alzheimer's disease: 12 months language training including use of a personal computer system: a pilot study.
    Ramström I
    Dev Neurorehabil; 2011; 14(3):156-63. PubMed ID: 21548856
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differences in anxiety among patients with early- versus late-onset Alzheimer's disease.
    Kaiser NC; Liang LJ; Melrose RJ; Wilkins SS; Sultzer DL; Mendez MF
    J Neuropsychiatry Clin Neurosci; 2014; 26(1):73-80. PubMed ID: 24515678
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Trajectories of Alzheimer disease-related cognitive measures in a longitudinal sample.
    Bilgel M; An Y; Lang A; Prince J; Ferrucci L; Jedynak B; Resnick SM
    Alzheimers Dement; 2014 Nov; 10(6):735-742.e4. PubMed ID: 25035155
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Diagnosis of Alzheimer's disease in Brazil: cognitive and functional evaluation. Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology].
    Nitrini R; Caramelli P; Bottino CM; Damasceno BP; Brucki SM; Anghinah R;
    Arq Neuropsiquiatr; 2005 Sep; 63(3A):720-7. PubMed ID: 16172733
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Clinician Interview-Based Impression (CIBI): a clinician's global change rating scale in Alzheimer's disease.
    Knopman DS; Knapp MJ; Gracon SI; Davis CS
    Neurology; 1994 Dec; 44(12):2315-21. PubMed ID: 7991118
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of unawareness on rehabilitation outcome in a randomised controlled trial of multicomponent intervention for patients with mild Alzheimer's disease.
    Fernández-Calvo B; Contador I; Ramos F; Olazarán J; Mograbi DC; Morris RG
    Neuropsychol Rehabil; 2015; 25(3):448-77. PubMed ID: 25121567
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A randomised pilot study to assess the efficacy of an interactive, multimedia tool of cognitive stimulation in Alzheimer's disease.
    Tárraga L; Boada M; Modinos G; Espinosa A; Diego S; Morera A; Guitart M; Balcells J; López OL; Becker JT
    J Neurol Neurosurg Psychiatry; 2006 Oct; 77(10):1116-21. PubMed ID: 16820420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.